This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of the Therapeutic Vaccine (ISA101) to Treat...
Clinical trial

Study of the Therapeutic Vaccine (ISA101) to Treat Advanced or Recurrent Cervical Cancer (CervISA)

Read time: 1 mins
Last updated:18th Apr 2014

The purpose of the study is to assess the safety, tolerability and to assess the HPV-specific immune responses of different doses of ISA101 vaccine with or without pegylated IFNα as combination therapy with carboplatin and paclitaxel.

Category Value
Study start date 2014-04-18

View full details